Catalyst Financial Partners LLC Dia Medica Therapeutics Inc. Transaction History
Catalyst Financial Partners LLC
- $455 Billion
- Q2 2024
A detailed history of Catalyst Financial Partners LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Catalyst Financial Partners LLC holds 38,457 shares of DMAC stock, worth $167,287. This represents 0.02% of its overall portfolio holdings.
Number of Shares
38,457
Previous 36,267
6.04%
Holding current value
$167,287
Previous $94.3 Million
20.31%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding DMAC
# of Institutions
34Shares Held
3.84MCall Options Held
1.3KPut Options Held
1K-
Vanguard Group Inc Valley Forge, PA1.02MShares$4.43 Million0.0% of portfolio
-
First Manhattan CO New York, NY839KShares$3.65 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX483KShares$2.1 Million3.48% of portfolio
-
Bleichroeder LP New York, NY382KShares$1.66 Million0.41% of portfolio
-
Geode Capital Management, LLC Boston, MA237KShares$1.03 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $115M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...